iCoat Medical has been given the opportunity to present our research at the 29th International Congress of The Transplantation Society to be held in Buenos Aires in September 2022.
Chief Medical Officer Alireza Biglarnia will give a speech entitled “TUM012 – a new polymer for ex vivo allograft coating to minimize post-reperfusion thromboinflammation in kidney transplantation”.
“The TTS congress is a great opportunity to increase the global awareness of the potential of iCoat Medical and establish new potential collaborations with key stakeholders in the transplantation field.” says iCoat Medical’s CMO Alireza Biglarnia.
For more information, please contact:
Alireza Biglarnia, CMO – iCoat Medical AB
Peder Waern, CEO – iCoat Medical AB